Please login to the form below

Not currently logged in
Email:
Password:

MIT chief financial officer joins Moderna Therapeutics

Israel Ruiz to serve as audit committee chair on its board of directors

US-based biotech Moderna Therapeutics has appointed Israel Ruiz to its board of directors to serve as audit committee chair.

Ruiz is currently executive vice president, treasurer and chief financial officer at Massachusetts Institute of Technology (MIT), where he is responsible for leading all of the institute's administrative and financial operations.

Before taking on his current role in 2011, Ruiz held a number of leadership positions at MIT, including vice president of finance, and lead the institute's digital learning technologies drive.

Ruiz also serves as audit committee chair on Fortive's board of directors, an industrial growth technology specialist.

Dr Noubar Afeyan, co-founder and chairman of Moderna Therapeutics, said: “We are delighted to welcome Israel to Moderna's board of directors.

“His progressive leadership at MIT has helped ensure the continued, unparalleled contributions of the institute on a regional, national and global scale, through education, innovation and entrepreneurship.

“We look forward to leveraging Israel's insights as Moderna evolves into a leading, clinical stage biotechnology company by harnessing the promise of messenger RNA science to improve lives.”

1st March 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics